Exhibit
31.2





CERTIFICATION PURSUANT TO RULE 13a-14 OF THE
SECURITIES EXCHANGE ACT OF 1934





I, Eugene
Boyle, certify that:





1.  I
have reviewed this annual report on Form 10-K of Samaritan Pharmaceuticals,
Inc.;





2. Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact  necessary to make the
statements made, in light of the  circumstances  under which
such statements were made, not misleading with respect to the period covered by
this report;





3.  Based  on
my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows
of the registrant as of, and
for, the periods presented in this report;





4.  The
registrant's other certifying officer and I are responsible for establishing and
maintaining  disclosure  controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal  control
over financial reporting  (as defined in Exchange Act
Rules  13a-15(f) and  15d-15(f),  for the
registrant and have:





a)  Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the registrant,  including its consolidated
subsidiaries,  is made known to us by others within those entities,
particularly during the period in which  this  report is
being prepared;





b)
Designed such internal control over financial reporting, or caused such
internal  control  over  financial  reporting  to  be  designed
under our supervision, to provide reasonable  assurance regarding the
reliability of financial reporting and  the  preparation
of  financial statements for external  purposes in
accordance with generally accepted accounting principles;





c)
Evaluated the effectiveness of the registrant's  disclosure controls
and procedures and presented in this  report
our  conclusions about the effectiveness of the disclosure controls
and procedures,  as of the end of the period covered by this report
based on such evaluation; and





d)
Disclosed in this report any change in the registrant's internal control over
financial  reporting that occurred during the registrant's most recent
fiscal  quarter (the  registrant's  fourth fiscal
quarter in the case of an annual report) that has
materially  affected, or is reasonably likely to
materially  affect,  the  registrant's internal
control over financial reporting; and





5. The
registrant's other certifying officer and I have disclosed,  based on
our most recent  evaluation of internal control
over  financial  reporting, to the registrant's auditors and
the audit committee of registrant's board of directors (or persons performing
the equivalent functions):





a)
All  significant  deficiencies and material
weaknesses  in the  design  or operation of
internal control over financial  reporting which are reasonably likely
to adversely affect the registrant's ability to record, process, summarize and
report financial information; and





b) Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal control over financial
reporting.




Date:
                June
      17, 2009/s/
      Eugene BoyleEugene
      Boyle
                  Chief
      Financial Officer
                  Chief Operations Officer
                  (Principal Financial
      Officer)